Back to all news
AI Model Enhances Prediction of Infection Risks from Oral Mucositis in Stem Cell Transplant Patients
Researchers developed an explainable AI tool that accurately predicts infection risks related to oral mucositis in hematopoietic stem cell transplant patients.
Key Details
- 1Patients with oral mucositis after HSCT are almost 4x more likely to develop serious infections.
- 2A new AI-driven nomogram using demographic and clinical features shows superior predictive accuracy versus traditional models.
- 3Explainable AI provided clinicians with rationale for predictions, enabling targeted preventive care.
- 4Meta-analysis identified high-risk groups and specific risk factors such as chemotherapy types, age, and kidney issues.
- 5Researchers are working towards broad clinical adoption, including validation for other adverse events in cancer therapy.
- 6Findings were recently published in the journal Cancers and presented at MASCC 2025.
Why It Matters
This work leverages advanced AI to proactively identify high-risk cancer patients, supporting multidisciplinary care and personalizing preventive strategies. Enhanced prediction of adverse events can improve outcomes, reduce complications, and optimize resource use in cancer therapy.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.